-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Anebulo Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Gross history and growth rate from Q2 2020 to Q2 2025.
- Anebulo Pharmaceuticals, Inc. Deferred Tax Assets, Gross for the quarter ending June 30, 2025 was $7.98M, a 24.5% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)